-+ 0.00%
-+ 0.00%
-+ 0.00%

MAPLIGHT THERAPEUTICS INC : LEERINK PARTNERS INITIATES COVERAGE WITH OUTPERFORM RATING; PRICE TARGET $30

Reuters·11/21/2025 12:16:08

Please log in to view news